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IL-7 and IL-7Ra bind the gc receptor, forming a
complex crucial to several signaling cascades
leading to the development and homeostasis of
T and B cells. We report that the IL-7Ra ectodomain
uses glycosylation to modulate its binding constants
to IL-7, unlike the other receptors in the gc family. IL-7
binds glycosylated IL-7Ra 300-fold more tightly than
unglycosylated IL-7Ra, and the enhanced affinity is
attributed primarily to an accelerated on rate. Struc-
tural comparison of IL-7 in complex to both forms of
IL-7Ra reveals that glycosylationdoes not participate
directly in the binding interface. The SCID mutations
of IL-7Ra locate outside the binding interface with
IL-7, suggesting that the expressed mutations cause
protein folding defects in IL-7Ra. The IL-7/IL-7Ra
structures provide a window into the molecular
recognition events of the IL-7 signaling cascade and
provide sites to target for designing new therapeutics
to treat IL-7-related diseases.
INTRODUCTION
IL-7, IL-7Ra, and gc form a ternary complex that plays funda-
mental roles in extracellular matrix remodeling, development,
and homeostasis of T and B cells (reviewed in Mazzucchelli and
Durum, 2007). IL-7Ra also crossreacts to form a ternary complex
with thymic stromal lymphopoietin (TSLP) and its receptor
(TSLPR), and activates the TSLP pathway, resulting in T and den-
tritic cell proliferation in humans and further B cell development in
mice (Leonard, 2002). Tight regulation of the signaling cascades
activated by the complexes is therefore crucial to normal cellular
function. Understimulation of the IL-7 pathway caused by muta-
tions in the IL-7Ra ectodomain inhibits T and B cell development,
resulting in patients with a form of severe combined immunode-
ficiency (SCID) (Giliani et al., 2005; Puel et al., 1998). Overstimu-
lation of the pathways leads to allergic rhinitis, autoimmunity,
heart disease, and proliferation of cancers (reviewed in Sportes
and Gress, 2007). In clinical trials of patients with hepatitis and
recovering cancer patients, IL-7 is being tested to spark T cell
development and expansion (reviewed in Sportes and Gress,
2007).54 Structure 17, 54–65, January 14, 2009 ª2009 Elsevier Ltd All righIL-7 and IL-7Ra belong to the gc family of cytokine receptors,
which includes IL-2, -4, -9, -15, -21, and receptors. The ILs and
ectodomains of the receptors share <15% sequence identity
with each other including the binding interfaces (see Figure S1
available online). Besides binding gc, all of the ILs and receptors
in the gc family are glycoproteins. Despite the universal glycosyl-
ation of the gc family, glycosylation has not been vital to the
binding interactions among family members. Studies show that
glycosylation plays no role in complex formation between IL-2
(Rickert et al., 2004), -4 (Hage et al., 1999), -15 (Matsumoto
et al., 2003), -21 (Zhang et al., 2003), and receptors. Three
Asns of IL-7 and six Asns of the IL-7Ra ectodomain may be N-
linked glycosylated from the Asn-X-Ser/Thr recognition motif.
Glycosylation of IL-7 does not affect its binding/function to IL-
7Ra (Goodwin et al., 1989). It remains an open question to the
importance of glycosylation of the IL-7Ra in binding and func-
tion.
To our knowledge for the first time among gc family members,
we report that glycosylation is important to the interaction
between IL-7 and IL-7Ra. We compare the binding constants of
IL-7 to unglycosylated and glycosylated IL-7Ra and show that
the enhanced binding affinity of IL-7 to glycosylated IL-7Ra
results primarily from an accelerated on rate. Furthermore, we
have determined the crystal structures of IL-7 complexes bound
to unglycosylated IL-7Ra at 2.7 A˚ and glycosylated IL-7Ra at
2.9 A˚. Glycosylation of IL-7Ra does not induce large conforma-
tional changes in the complexes and the glycans are located
outside the IL-7/IL-7Ra binding interface, indicating an indirect
mechanism of binding enhancement. The IL-7/IL-7Ra binding
interface displays the smallest, least polar, and least specific
interface in comparison to other IL/receptor complexes in the
gc family. We map the mutations found in patients with SCID
onto the IL-7Ra structure and show that they are localized
outside the binding interface. Lastly, we discuss the possible
mechanism of glycosylation of IL-7Rawith its binding interaction
with IL-7.
RESULTS
IL-7/IL-7Ra Biosensor Analysis
The binding kinetics and affinities observed for the interactions
between IL-7 and unglycosylated or glycosylated IL-7Ra reveal
the importance of glycosylation in formation of the IL-7/IL-7Ra
complex. Surface plasmon resonance (SPR) binding kineticsts reserved
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Structures of the IL-7/IL-7Ra ComplexFigure 1. Binding Kinetic Sensorgrams for the IL-7/IL-7Ra Interaction Determined Using SPR
(A) Binding kinetics between unglycosylated IL-7 and IL-7Ra, both from E. coli (EC).
(B and C) Binding kinetics of IL-7 (EC) to glycosylated IL-7Ra from Chinese hamster ovary (CHO) and Schneider (S2) insect cells, respectively.
(D) Binding kinetics of IL-7 to PNGase F-treated IL-7Ra (S2).
(E) Binding kinetics between IL-7 (EC) and Endo H-treated IL-7Ra (S2).
The binding kinetics sensorgrams are in black. The red curves are global fits of the SPR data to a two-step binding reaction model to determine the binding
kinetics.collected on IL-7 from Escherichia coli (EC) and unglycosylated
IL-7Ra (EC), glycosylated IL-7Ra from Chinese hamster ovary
(CHO) cells, and glycosylated IL-7Ra from Schneider insect
(S2) cells display biphasic kinetics that fit best to a two-state
reaction mechanism with two on- and off-rate constants
(Figure 1; Table 1). IL-7 binds to glycosylated IL-7Ra (CHO/S2)
with k1 rates that are 7100-fold (CHO) and 5200-fold (S2) faster
than the k1 rate of IL-7 binding to unglycosylated IL-7Ra (EC).
The k2 rates of IL-7 binding to the IL-7Ra glycoforms (CHO/S2)
display negligible effects in the comparison of IL-7 binding to un-
glycosylated IL-7Ra (4.9-fold for CHO to EC and 1.7-fold for S2
to EC). Similarly, the two off rates, k1 and k2, also show negli-
gible effects in the comparison of IL-7 binding to glycosylated IL-
7Ras (CHO/S2) and unglycosylated IL-7Ra (7.1- and 2.4-fold for
CHO to EC, and 5.9- and 3.4-fold for S2 to EC). Thus, the 300-
fold enhancement in Kd of IL-7 and glycosylated IL-7Ra (CHO/
S2) relative to IL-7 and unglycosylated IL-7Ra (EC) derives
primarily from an accelerated k1 rate.
The enhanced k1 and Kd of IL-7 to glycosylated IL-7Ra relative
to unglycosylated IL-7Ra arises directly from N-glycosylation,Structure 17but is insensitive to glycan composition. Binding studies of
IL-7 with IL-7Ra (S2) treated with peptide:N-glycosidase F
(PNGase F)—an enzyme that removes N-glycans and converts
the Asns to Asps—resemble those performed on IL-7 and ungly-
cosylated IL-7Ra (EC), indicating that the differences in binding
result from N-glycosylation and not some attribute of using
different cell expression systems (Figure 1D). The binding
constants were also measured for IL-7 binding to glycosylated
IL-7Ra expressed in two cell lines (CHO and S2) that modify
proteins with different N-glycosylation patterns (Figures 1B
and 1C). Unlike CHO cells, S2 cells do not incorporate complex
branches with sialic acids or galactoses onto proteins, but
express proteins with paucimannose hybrid glycans (Aoki
et al., 2007). Even though the glycosylation patterns on IL-7Ra
from S2 cells differ from those on IL-7Ra from CHO cells, the
binding constants were comparable.
Binding is likely unaffected by the variations in glycanbranching
because the proximal N-acetylglucosamine (GlcNAc) is wholly
responsible for the large enhanced k1 on rate and affinity of IL-7
to glycosylated IL-7Ra. The binding constants measured for, 54–65, January 14, 2009 ª2009 Elsevier Ltd All rights reserved 55
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Structures of the IL-7/IL-7Ra ComplexTable 1. Binding Constants of IL-7 to IL-7Ra Variants
k1 (M
1s1) k1 (s
1) k2 (s
1) k2 (s
1) Kd
a IC50
b
wt-IL-7 (EC)
IL-7Ra (EC) 2.1 3 102 1.7 3 102 4.2 3 103 1.2 3 103 18 mM 3.0 mM
IL-7Ra (CHO) 1.5 3 106 1.2 3 101 8.6 3 104 2.9 3 103 62 nM ND
IL-7Ra (S2) 1.1 3 106 1.0 3 101 2.5 3 103 4.1 3 103 56 nM 190 nM
IL-7Ra (S2 Endo H) 1.1 3 106 1.1 3 101 1.4 3 103 6.2 3 103 82 nM 340 nM
IL-7Ra (S2 PNGase F) 2.4 3 103 8.3 3 102 3.5 3 103 2.3 3 103 14 mM 2.2 mM
E106A-IL-7 (EC)
IL-7Ra (S2) 1.9 3 105 1.7 3 102 3.2 3 103 1.0 3 103 21 nM ND
IL-7Ra (S2 PNGase F) 6.9 3 103 6.9 3 102 6.0 3 103 9.8 3 104 1.4 mM ND
ND, not determined. Surface plasmon resonance experiments were performed in 10 mM HEPES (pH 7.4), 150 mMNaCl, 3 mM EDTA, 0.005% Tween
20 at 25C. Experiments were triplicated with standard errors < 10% for the rate constants.
a Kd = k1k2/k1(k2 + k2).
b Competition ELISA experiments were performed in PBS buffer (pH 7.4) with 0.05% Tween 20 at 25C.IL-7 to glycosylated IL-7Ra (S2) treated with endoglycosidase H
(Endo H)—an enzyme that cleaves the bond between the first
two GlcNAcs of hybrid mannose glycans like that produced
fromS2 cells, leaving the proximal GlcNAc—were similar to those
measured for IL-7 to the fully glycosylated IL-7Ra (CHO/S2)
(Figures 1B, 1C, and 1E). The SPR experiments measuring the
affinities between IL-7 and unglycosylated IL-7Ra (EC) and glyco-
sylated IL-7Ra (S2) untreated and treated with PNGase F or Endo
H were further confirmed by competition ELISA experiments
(Figure S2; Table 1).
IL-7/IL-7Ra Crystal Structure Determinations
We determined the crystal structures of IL-7 (EC, E106A muta-
tion) bound to both unglycosylated and glycosylated forms of
the IL-7Ra at 2.7 and 2.9 A˚ resolution, respectively. Similar
binding constants were observed between the interactions of
E106A-IL-7 with both forms of IL-7Ra compared to wt-IL-7
(Table 1). The unglycosylated complexwas refinedwith a crystal-
lographic R value (Rcryst) of 0.212 (Rfree of 0.266; Table S1). Two
unglycosylated IL-7/IL-7Ra (EC) complexes were located within
the asymmetric unit. The glycosylated complex was refined to
Rcryst and Rfree values of 0.234 and 0.267, respectively (Table
S2). One glycosylated IL-7 (EC)/IL-7Ra (S2) complexwas located
within the asymmetric unit.
IL-7 Structures
IL-7 adopts an up-up-down-down four-helix bundle topology
with two crossover loops (Figure 2A). The a helices A–D vary in
length from 13 to 22 residues, similar to the lengths of helices in
other gc ILs. A turn of a p helix from T12–M17 in helix A is unique
to IL-7 and stabilizes the IL-7/IL-7Ra interaction. The first cross-
over loopof 23 residues contains 1.5 turns ofa helix (mini-helix 1),
whereas themajority of the second crossover loop of 33 residues
could not be traced in any of the three complex structures. The
first crossover loop in IL-7 is positioned differently between the
IL-7/IL-7Ra complex structures, probably from local crystal
packing contacts.
The crystal structures of IL-7 clearly showed electron density
to trace two out of three disulfide bonds (Figure 2A). The disulfide
bonds are C34-C129, C47-C141, and C2-C92. This disulfide
bond patterning is in contrast to homology models of IL-7 and56 Structure 17, 54–65, January 14, 2009 ª2009 Elsevier Ltd All rightbiochemical data that predicted different locations by swapping
the C47-C141 and C2-C92 disulfide bonds for C2-C141 and
C92-C141 (Cosenza et al., 1997, 2000). Whereas the electron
density allowed tracing of the C34-C129 and C47-C141 disulfide
bonds, it was too weak near the N terminus (residues 1–6[7]) and
the end of helix C proceeding into the second crossover loop
(residues 89–123) to trace the third disulfide bond between
C2 and C92. Similarly, electron density was absent for the
N-terminal disulfidebondof a structure of IL-10 (Yoonet al., 2006).
Previous studies indicated that W142 of helix D, the sole Trp
of IL-7, was critical to the interaction between IL-7 and gc
(Cosenza et al., 2000; vanderSpek et al., 2002). However, the
IL-7 structures show the burial of W142 into the hydrophobic
core of the four-helix bundle, with the N3 forming a hydrogen
bond (H bond) to T86 Og1 (Figure 2B). Thus, mutation of W142
likely causes defective folding of helix D and/or complete unfold-
ing of IL-7, resulting in the reported decreases in cell assays
(Cosenza et al., 2000; vanderSpek et al., 2002).
IL-7Ra Structures
IL-7Ra forms a L-shaped architecture similar to other IL recep-
tors in the gc family, as well as other related receptors in the cyto-
kine receptor class I (CRH I) superfamily, including receptors for
growth hormone, erythropoietin, and other ILs (Figure 2C). The
219 residue IL-7Ra ectodomain folds into two fibronectin type
III (FNIII) domains connected by a 310-helical linker. The elbow
angle (3) between the FNIII domains was similar in both IL-7Ra
structures, ranging from 74 to 75 (Table S3). In the D1 domain
of IL-7Ra, a disulfide bond (C22R-C37R) conserved among CRH I
family members bridges b strands A1 and B1. Two other disul-
fide bonds unique to IL-7Ra connect b strands C1 to C01
(C54R-C62R) and F1 to G1 (C88R-C98R). Another defining feature
of the CRH I family found in IL-7Ra is the WSXWS sequence
motif in the D2 domain. In IL-7Ra, theWSXWSmotif forms exten-
sive p cation side-chain stacking interactions critical to the SCID
mutations discussed below.
IL-7Ra contains six potential N-glycosylation sites: N29R,
N45R, N131R, N162R, N212R, and N213R. The electron density
of glycosylated IL-7Ra allowed tracing of two GlcNAcs for three
different Asns: N29R, N45R, and N131R (Figures 2C–2E). The side
chain of N162R was clear in the electron density, but not itss reserved
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dues E210R-D219R, neither N212R nor N213R could be traced.
All of the Asn side chains modeled in the glycosylated structure
were also observable in the unglycosylated structures, except
residue N29R, indicating extensive side-chain mobility. All of
the glycans of the IL-7Ra structure are extending away from
IL-7Ra, and none of the glycans are contacting other residues
on IL-7Ra except the second GlcNAc (NAG 903) attached to
N45R, whose O6 glycan group is H bonding to A48R N (3.2 A˚).
Comparison of IL-7 Bound to Unglycosylated
and Glycosylated IL-7Ra
Although the overall structures of IL-7 bound to both forms of
IL-7Ra are similar, a change in the position of the predicted gc
binding interface suggests that glycosylation may also modulate
the binding of gc to IL-7/IL-7Ra (Figure 3A). The two unglycosy-
lated complexes superimpose with a root-mean-square devia-
tion (rmsd) of 0.29 A˚ (164 Ca) for all secondary (2) structural
elements. Superimposing the 2 structural elements of the glyco-
sylated structure onto either unglycosylated complex yield
rmsds of 0.53 and 0.64 A˚ (159 Ca), demonstrating that the
glycans do not induce large conformational changes. Indepen-
dently, the IL-7 four-helix bundles superimpose with an rmsd
of 0.52 A˚ (72 Ca, glycosylated structure to both unglycosylated
Figure 2. Structural Characterization of IL-7
with Unglycosylated and Glycosylated
Forms of IL-7Ra
(A) One of the unglycosylated IL-7 structures
oriented by placement of methionine residues
into the experimentally determined SeMet heavy
atoms (red spheres). Unobservable electron
density in the second crossover loop is shown as
a black dashed line. The E106A mutation in IL-7,
which was used for both the unglycosylated and
glycosylated complex structures, is highlighted
as a green sphere.
(B) Close-up view of the hydrophobic core around
the sole Trp residue of IL-7, W142. The
sA-weighted 2Fo  Fc electron density map (blue
mesh) contoured at 1.0s. W142 N31 forms an
H bond to T86 Og1 (black dashed line).
(C) Ribbon diagram of the glycosylated IL-7 (EC,
green)/IL-7Ra (S2, purple) complex. Disulfide
bonds are shown in yellow. IL-7Ra residues are
labeled with a subscript R. The observed IL-7Ra
GlcNAcs are shown as white sticks.
(D) Molecular surface of the glycosylated IL-7/
IL-7Ra complex colored as in (C).
(E) Simulated annealed sA-weighted omit electron
density maps (blue mesh) contoured at 1.0s for
the modeled GlcNAcs attached to N29R, N45R,
and N131R.
structures), and the two IL-7Ra FNIII
domains superimpose with an rmsd of
0.37 A˚ (86 Ca, glycosylated structure to
both unglycosylated structures).
The surface on IL-7 where gc is pre-
dicted to bind (helices A and D) experi-
enced the largest structural change
between the unglycosylated and glycosylated structures
(Figure 3A). When the complex structures are aligned on the IL-
7Ras using both D1 and D2 domains, the IL-7 four-helix bundles
shift relative to one another with a displacement of individual
helices ranging from 1 (helix B) to 5 (helix D) (Figure 3A). If the
complex structures are aligned on the IL-7 four-helix bundles,
then theD2domains of thea receptors rotate accordingly. Similar
displacements are observed between the glycosylated complex
with both unglycosylated complexes, potentially ruling out
changes induced by crystal contact formation. Thus, glycosyla-
tion of IL-7Ra may be positioning the four-helix bundle of IL-7
and/or the domains of the IL-7Ra in a manner conducive for gc
binding. Further studies will probe whether glycosylation of IL-
7Ra modulates the binding constants, structure, and function
of gc.
IL-7/IL-7Ra Interface
IL-7 is positioned at the elbow region connecting the D1 and D2
domains of IL-7Ra (Figures 2C, 2D, and 3A). The interface largely
comprises hydrophobic and van der Waals (VDW) interactions,
although a few intermolecular H bonds exist in the binding inter-
face (Figures 3B–3E; Table 2). Residues in helices A and C of IL-7
contact residues in the six loop regionsconnecting theb sheetsof
the IL-7RaFNIII domains (Figures 3Cand3D).On average, apolarStructure 17, 54–65, January 14, 2009 ª2009 Elsevier Ltd All rights reserved 57
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structures over polar residues (47% versus 33%; Table 3). The
two unglycosylated complexes in the asymmetric unit bury 735
and 720 A˚2 of surface area, whereas the glycosylated complex
buries 705 A˚2 of surface area (Table 3).
Glycosylation of IL-7Ra does not influence its interaction with
IL-7 through direct contacts at the binding interface with IL-7
(Figure 2D). The glycans attached to N45R face away from IL-7
on the back side of the D1 domain of IL-7Ra. The glycans
attached to N29R and N131R are 10 and 15 A˚ away from the
closest IL-7 atom, respectively. Even though N162R, N212R,
and N213R could not be visualized in the electron density, their
potentially attached glycans are not near the interface either.
Ongoing biophysical and structural studies of the free states of
unglycosylated and glycosylated IL-7 and IL-7Ra will determine
Figure 3. Structural Comparison between
Unglycosylated and Glycosylated IL-7/
IL-7Ra Complexes
(A) Superimposition of the unglycosylated struc-
tures (wheat and blue) onto the glycosylated
structure (green) using the D1 and D2 domains of
the receptors.
(B) Molecular surface view of IL-7 and IL-7Ra high-
lighting the hydrophobic (orange) and hydrophilic
(lime green) residues in the binding interface.
(C and D) Bar graphs showing the amount of
buried surface area for IL-7 (C) and IL-7Ra (D) in
the unglycosylated (red bars) and glycosylated
(blue bars) complexes. Secondary structure
locations are labeled below the residues.
(E) Two views of the intermolecular interactions
observed between the IL-7/IL-7Ra unglycosylated
(wheat) and glycosylated (green) structures.
H bonds are depicted as dashes colored black
and green for the unglycosylated and glycosylated
complexes, respectively.
how glycosylation affects molecular
recognition events of IL-7Ra with IL-7.
The IL-7/IL-7Ra interfaces in all three
structures involve similar H bonds, except
for a couple of bonds andwater-mediated
interactions. The binding interfaces of
both complexes share four common
H bonds involving D74 and K81 of IL-7,
but each complex has additional H bonds
absent from the other complex (Figure 3E;
Table 2). In the glycosylated complex,
Q22 O31 from helix A forms a long
H bond with K138R Nz (3.4 A˚), whereas, in
the unglycosylated complex, the Y192R
Oh forms an H bond with Q11 N32
(3.2 A˚). Only one of the unglycosylated
complexes in the asymmetric unit has an
interface containing water-mediated
interactions. Of the six water-mediated
interactions observed in the unglycosy-
lated structure, two H bonds form
between the hydroxyl side chains of S19
of helix A and Y139R, and four H bonds form between the side
chain of E84 of helix C and the backbone carbonyls of V58R
and V60R in loop CC
01 of IL-7Ra (Figure 3E). The differences
observed in theH bonds among the three structures involve rota-
meric changes of the side chains requiring minimal energetic
costs going from one structure to another.
DISCUSSION
IL-7/IL-7Ra Binding Mechanism
IL-7/IL-7Ra displays a more complex binding mechanism in
comparison to other IL/receptor interactions in the gc family.
The binding kinetics of IL-7 with either unglycosylated or glyco-
sylated IL-7Ra involve a two-step reaction where an encounter
complex, (IL-7:IL-7Ra)*, is observed before reaching the final58 Structure 17, 54–65, January 14, 2009 ª2009 Elsevier Ltd All rights reserved
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kinetics of IL-2, -4, and -21 to their CRH I receptors were fit best
to a single-step reaction with a single on- and off-rate constant
(k1, k1) (Liparoto et al., 2002; Shen et al., 1996; Zhang et al.,
2003). An encounter complex of these complexes may exist,
but not observable using current methods. The significance of
the two-step binding reaction of the human IL-7/IL-7Ra interac-
tion and the dramatic enhancement of the k1 on rate of IL-7 to
glycosylated IL-7Ra are open questions that future studies will
explore. Of note, the interaction between mouse IL-7 and full-
length mouse IL-7Ra on a cell surface also displayed biphasic
binding kinetics (Park et al., 1990).
IL-7Ra SCID Mutations
The point mutations in IL-7Ra that have been identified in
patients suffering from SCIDmap to residues outside the binding
epitope with IL-7, but localize to residues in the hydrophobic
cores of the FNIII domains, cysteines of disulfide bonds, or the
WSXWS motif (Figure 4; reviewed in Giliani et al., 2005). Five
SCID mutations identified in the IL-7Ra D1 domain include
G8RR, S24RR, L35RR, C54RY, and C98RY. The G8RR mutation
could not be mapped onto the IL-7Ra structure because residue
G8 was not visible in the electron density of any of the IL-7Ra
structures. Ser24R Og forms a H bond to L130R O that will be
absent from the S24RR SCID mutation. The loss of this H bond
and the need to accommodate a large Arg side chain probably
Table 2. Potential Hydrogen Bonds in Unglycosylated
and Glycosylated IL-7/IL-7Ra Complexes
Unglycosylated IL-7/IL-7Ra Complex 1
IL-7 IL-7Ra Distance (A˚)
Asp74 Od1 Lys77 Nz 3.4
Asp74 Od1 Ser31 Og 3.2
Asp74 Od2 Lys77 Nz 3.1
Lys81 N3 Lys77 O 3.1
Gln11 N32 Tyr192 Oh 3.1
Wat-1 Ser19 (IL-7) Og 2.7
Wat-1 Tyr139 (IL-7Ra) Oh 2.6
Wat-15 Glu84 (IL-7) O31 3.5
Wat-15 Glu84 (IL-7) O32 3.6
Wat-15 Val58 (IL-7Ra) O 2.6
Wat-15 Val60 (IL-7Ra) O 3.7
Unglycosylated IL-7/IL-7Ra Complex 2
Asp74 Od1 Lys77 Nz 3.4
Asp74 Od1 Ser31 Og 3.3
Asp74 Od2 Lys77 Nz 3.1
Lys81 Nz Lys77 O 2.9
Gln11 N32 Tyr192 Oh 3.2
Glycosylated IL-7/IL-7Ra Complex
IL-7 IL-7Ra
Gln22 O31 Lys138 Nz 3.4
Asp74 Od2 Ser31 Og 3.3
Asp74 Od2 Lys77 Nz 2.9
Asp74 Od1 Lys77 Nz 3.6
Lys81 Nz Lys77 O 2.7Structure 17causes the S24RR mutation to destabilize the linker connecting
the D1 and D2 domains. The L35RR SCID mutation presumably
unfolds the FNIII domain by forcing a bulky, polar side chain into
the hydrophobic core of the D1 domain. SCID mutations C54RY
and C98RY each remove a disulfide bond from IL-7Ra, thereby
disrupting the folding/stability of the D1 domain.
SCID mutations in the D2 domain localize to or near the
WSXWS motif between W197R and S201R. The Trps, W197R
andW200R, of theWSXWSmotif participate in extensivep cation
interactions with Trp (W158R), Lys (K184R), and arginine (R186R
andR150R) side chains. TwoSCIDmutations convert whatwould
be residuesW197R and R186R to stop codons, resulting in termi-
nation ofmRNA. Three other SCIDmutations in theWSXWSmotif
include S198RN, W200RC, and S201RI. S198R and S201R rigidify
the D2 domain by orienting the G2 and F2 b strands through
several Ser side-chain to main-chain H bonds. The SCID muta-
tions S198RN and S201RI lack these critical H bonds. In addition
to disrupting the core of the p cation interactions, W200RC may
interfere with proper disulfide bond formation. Finally, SCID
mutations L115RR, P112RH, and P112RS probably destabilize
the hydrophobic core of the D2 domain. Studies of related
CRH I cytokine receptors (GHR and EpoR) reported the WSXWS
motif as crucial to proper folding of the ectodomains, binding of
ligands, and functions (Baumgartner et al., 1994; Hilton et al.,
1996).
IL-7/IL-7Ra Structural Comparison to gc Members
The binding interface between IL-7 and IL-7Ra differs from the
interfaces between other ILs and receptors in the gc family in
size, polarity, and specificity. The average buried surface area
of the IL-7/IL-7Ra interface is 720 A˚2, whereas the buried surface
areas of the IL-4/IL-4Ra binary and ternary complexes and IL-2/
IL-2Rb interfaces are 835, 778, and 1350 A˚2, respectively (Hage
et al., 1999; Laporte et al., 2008; Wang et al., 2005) (Table 3). The
IL-7/IL-7Ra interface predominantly involves apolar residues
(average 47% apolar, 33% polar), the IL-4/IL-4Ra interface polar
residues (27% apolar, 43% polar) (Hage et al., 1999; Laporte
et al., 2008), and the IL-2/IL-2Rb interface both apolar and polar
residues (24% apolar, 39% polar) (Wang et al., 2005) (Figure 5).
The IL-7/IL-7Ra interface comprises 5 H bonds, whereas the
IL-4/IL-4Ra and IL-2/IL-2Rb interfaces comprise 15, 14, and 8
H bonds, respectively (Hage et al., 1999; Laporte et al., 2008;
Table 3. Summary of Binding Interfaces of gc Complexes
Complex BSA (A˚2)a H Bonds Sc
b
% Polar
Residues
% Apolar
Residues
Unglyco IL-7/IL-7Ra 1 735 5 0.68 29.7 51.5
Unglyco IL-7/IL-7Ra 2 720 5 0.69 33.1 47.2
Glyco IL7/IL-7Ra 705 5 0.65 36.3 42.5
IL-2/IL-2Rb 1350 8 0.74 39.3 24.1
IL-4/IL-4 binary 835 15 0.74 39.7 30.8
IL-4/IL-4Ra ternary 778 14 0.70 46.0 22.2
Values were calculated fromPISA, CCP4, and the protein/protein interac-
tion server at http://www.bioinformatics.sussex.ac.uk/protorp/index.
html.
a Average buried surface area of the cytokine and receptor at the
interface.
b Shape complementarity of the interface., 54–65, January 14, 2009 ª2009 Elsevier Ltd All rights reserved 59
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Structures of the IL-7/IL-7Ra ComplexWang et al., 2005) (Table 3). Unlike the nonspecific hydrophobic
and VDW contacts that dominate the IL-7/IL-7Ra interface, side-
chain-specific hydrophilic contacts dominate the IL-4/IL-4Ra
interface flanked by hydrophobic residues, whereas a mixture
of hydrophobic and hydrophilic contacts comprise the interface
of IL-2/IL-2Rb (Hage et al., 1999; Wang et al., 2005). Moreover,
the IL-7/IL-7Ra interface has the lowest shape complementarity
value of 0.67 (average of three structures) compared with
0.74 and 0.72 (averaged) for the IL-2/IL-2Rb and IL-4/IL-4Ra
interfaces, respectively (Table 3). The IL-7/IL-7Ra interface is
therefore the smallest, least polar, and least specific of the three
interfaces.
The apolar, nonspecific nature of the IL-7/IL-7Ra interface and
overall charge of IL-7 and IL-7Ra suggest that electrostatics influ-
ence the IL-7/IL-7Ra interaction less than the IL-4/IL-4Ra interaction
but possibly more than the IL-2/IL-2Rb interaction. Electrostatic
attraction drives the IL-4/IL-4Ra interaction directly through charges
in the interface and the overall charge of the molecules (Hage et al.,
1999; Zhang et al., 2002b). The basic residues comprising the
binding surface of positively charged IL-4 (pI 9.0) interact directly
with the acidic and hydrophobic residues comprising the binding
surface of negatively charged IL-4Ra (pI 5.1) (Figure 5B). Electro-
statics play a less prominent role in the IL-2/IL-2Rb interaction,
because the overall charges of IL-2 (pI 7.1) and IL-2Rb (pI 6.7) are
neutral and the interface comprises both polar and apolar residues
(Wang et al., 2005) (Figure 5C). A long-range electrostatic attraction
may drive the interaction between IL-7 (pl 8.4) and IL-7Ra (pl 5.3)
through complementary overall charges of the molecules. Even
though apolar residues govern the IL-7/IL-7Ra interface, the IL-7
residues above and away from the interface are mainly basic, and
the IL-7Ra residues distributed throughout the receptor except
near the interface are mainly acidic (Figure 5A).
Figure 4. SCID Mutations Identified in
Patients Are Mapped onto the Structure of
the IL-7Ra Ectodomain
The WSXWS motif is depicted with yellow sticks
and gray transparent CPK representations.
H bonds between the backbone carbonyl of
L103R with the S24R Og (2.7 A˚) and S201R Og
with V185R N (3.0 A˚) are drawn as black dots.
SCID residues are labeled in red.
The orientation of the helices of the
four-helix bundle of IL-7 varies from that
of other gc ILs, possibly to present a
distinct gc binding epitope. Backbone
Ca superimpositions of the four-helix
bundles (helices A–D) of IL-2 from the
IL-2 quaternary complex (Wang et al.,
2005), IL-4 from the binary and ternary
complexes (Hage et al., 1999; Laporte
et al., 2008), and IL-21 (Bondensgaard
et al., 2007) onto IL-7 result in rmsds of
2.5 A˚ (60 Ca), 3.2 A˚ (62 Ca), 3.1 A˚
(62 Ca), and 2.4 A˚ (43 Ca), respectively
(Figure S3). Similar backbone rmsds of
each gc IL onto IL-7 were also obtained
by superimposing only helices A and C
or helices A, B, and C (Figure S3). The angular changes between
helixDare smallest for IL-2 and IL-21 in comparison to IL-7 for the
three different superimpositions by 7–12 for IL-2 and 9–12 for
IL-21. The IL-4 binary and ternary complexes display larger
helix D changes in comparison to IL-7, ranging from 14 to 26
depending on which helices were superimposed. These angular
changes of the helices, particularly of helix D, presumably allow
each IL to present a different binding surface for gc. The gc
must differentiate among all of its different binding partners to
carefully regulate signaling pathways. IL-7 possibly distinguishes
itself within the four-helix bundle framework common to all gc ILs
by not only varying the amino acid composition of helices A andD
on its predicted gc binding surface but also by angular displace-
ment of its helices.
Extending beyond the orientations of the four-helix bundle
arrangements, the differences in the angular geometries
between the FNIII D1 and D2 domains of IL-7Ra, IL-2Rb, and
IL-4Ra also suggest that either the IL-7/IL-7Ra complex, gc, or
a combination of both structures must change conformation
from the ones observed in both the IL-2 quaternary and IL-4
ternary complexes to form a productive IL-7/IL-7Ra/gc complex.
Analysis was performed to determine FNIII domain geometries of
the gc family members with the new IL-7Ra structures as
described (Deivanayagam et al., 2000). Superimposition of either
the D1 or D2 domains of IL-7Ra from both structures or the
IL-4Ra structures (binary and ternary complexes) onto IL-2Rb
reveals that the elbow angle connecting the D1 and D2 domains
varies slightly among the five structures (Figures 6A and 6B;
Table S3). The changes of twist (t) and swivel (s) angles,
however, show that the rotations relating the D1 and D2 domains
of IL-7Ra are generally larger (D1 versus D2 superimpositions:
Dt = 14, 21;Ds = 25, 1) than IL-4Ra from the binary or ternary60 Structure 17, 54–65, January 14, 2009 ª2009 Elsevier Ltd All rights reserved
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Structures of the IL-7/IL-7Ra ComplexFigure 5. Electrostatic Surface Potentials of gc ILs and Receptors
(A) IL-7 and glycosylated IL-7Ra.
(B) IL-4 and IL-4Ra from Protein Data Bank (PDB) ID code 1IAR.
(C) IL-2 and IL-2Rb from PDB ID code 2BFI. The electrostatic potential
surfaces are displayed at a level of ±5 kBT/e (blue, +; red, ). Contact areas
between the interleukins and their receptors are marked by a dashed circle.Structure 1complexes (D1 versus D2 superimpositions: binaryDt = 17, 19;
Ds = 10, 9; ternary Dt = 12, 11; Ds = 9, 1) in relation to
IL-2Rb. The considerable differences between the t ands angles
relating the D1 and D2 domains of IL-7Ra with either IL-2Rb or
IL-4Ra prevent the unobstructed docking of the gc conformation
from the IL-2 or IL-4 structures onto the IL-7/IL-7Ra structure.
Superimposing the D1, D2, or both D1/D2 domains of the IL-7/
IL-7Ra complex onto the corresponding domains of either the
IL-2 quaternary or IL-4 ternary structures result in steric clashes
between the D2 domains of IL-7Ra and gc, steric clashes
between helix D and loop 1 of IL-7 with gc, or helices A/D of
IL-7 being too far to contact gc (Figures 6C–6E; Figure S4).
Thus, gc likely uses a different conformation from the one
observed in either the IL-2 or IL-4 structures to productively
form the IL-7/IL-7Ra/gc ternary complex.
Model of the IL-7/IL-7Ra/gc Complex
Data implicate ahandful of residueson IL-7andgc as important to
productive formation of the IL-7/IL-7Ra/gc ternary complex
(Olosz and Malek, 2002). Mutagenesis studies of IL-7 have yet
to identify any residues important to the binding of gc; however,
structural and mutagenesis data of other gc family members
(Hage et al., 1999; Letzelter et al., 1998;Wanget al., 2005) consis-
tently implicate helicesAandD in thebindingofgc. Analysis of the
IL-7 structure in the IL-7/IL-7Ra complex reveals seven solvent-
exposed residues on helix D that could interact with gc: R133,
H136, E137,K139, T140,N143, andS144 (Figure 7).Mutagenesis
studies of gc have identified three residues, Y103gc, G210gc, and
N128gc, and the C160gc-C209gc disulfide bond, as crucial to the
productive formation of the IL-7/IL-7Ra/gc complex (Olosz and
Malek, 2002). Y103gc, G210gc, and the disulfide bond are also
critical to the formation of complexes involving IL-2, -4, -15,
and -21, whereas N128gc has been identified as important for
complexes involving IL-7 and IL-21 (Olosz and Malek, 2002;
Zhang et al., 2002a, 2003).
Using mutagenesis data (Olosz and Malek, 2002; Zhang et al.,
2002a, 2003) and the IL-7/IL-7Ra and gc (Laporte et al., 2008;
Wang et al., 2005) structures, we built a structure of the IL-7/
IL-7Ra/gc complex to demonstrate the potential conformational
change that gc must undergo to form an IL-7 ternary complex
(Figure 7). The docking of gc was guided by bringing the
Y103gc side chain, which packs in similar regions on both the
IL-2 and IL-4 gc structures, within contact with K139 and T140
of IL-7. The model does not account for any interaction between
helix A and the loop regions of gc, with the closest potential
contact between the two being 5 A˚. Also unlikely is the absence
of interactions between the D2 domains of gc and IL-7Ra. The
IL-2 and IL-4 gc structures revealed large binding interfaces
between the D2 domains of gc with IL-2Rb (1750 A˚
2 surface
area burial and 17 H bonds; Wang et al., 2005) and gc with
IL-4Ra (1350 A˚2 surface area burial and 4 H bonds; Laporte
et al., 2008). The closest contact between side chains of the D2
domains of gc and IL-7Ra is 7 A˚ (Figure 7). If the D2 domain
interactions observed in both the IL-2 and IL-4 structures are
conserved in the IL-7 complex, then gc must adopt a different
conformation from the ones observed in the IL-2 and IL-4 struc-
tures (Laporte et al., 2008;Wanget al., 2005). Amore acute elbow
angle between the D1 and D2 domains of gc may allow interac-
tions between helix A and the gc loops and between the D27, 54–65, January 14, 2009 ª2009 Elsevier Ltd All rights reserved 61
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Structures of the IL-7/IL-7Ra Complexdomains of IL-7Ra and gc. Crystal structure determination of the
IL-7/IL-7Ra/gc complex is under way.
Structural-Functional Roles of IL-7Ra Glycosylation
Glycosylation of IL-7Ra could contribute to the interaction
between IL-7 and IL-7Ra through at least two different mecha-
nisms. First, glycosylation may be affecting the overall electro-
static potential of IL-7Ra. The global complementary charges
of IL-7 (highly positive) and IL-7Ra (highly negative)may influence
the binding of IL-7 and IL-7Ra, and glycosylation may, in turn,
modulate those charges. For example, the negatively charged
sialic acids increased the negative charge on erythropoietin
(EPO) (dropping the pI from 9.2 to 4.6), thereby exacerbating
the charge differential between EPO and its receptor decreasing
the binding affinity by only 12-fold (9-fold slower on rate
between aglycosylated and glycosylated EPO), but increasing
serum half-life (Darling et al., 2002). Yet, the degree of branching
and the types of glycans typically determine towhat extent glyco-
sylation may affect the electrostatic potential, and the IL-7/
IL-7Ra interaction was insensitive to variations in branching
and glycans. Because glycosylated IL-7Ra binds IL-7 with the
same affinity and k1 on rate irrespective of branching and glycan
type, and even with only the primary GlcNAc, glycosylation may
affect the binding constants through a local rather than global
electrostatic mechanism.
Second, glycosylation may also alter the conformations
sampled by free IL-7Ra. Free IL-7Ra is likely undergoing confor-
mational exchange between at least two states: nonbinding
IL-7Ra and IL-7Ra poised to bind IL-7. The reason the binding
kinetics fit best to a two-state exchange mechanism is likely
that nonbinding IL-7Ra and IL-7Ra poised to bind IL-7 are in
equilibrium with one another. Glycosylation may affect the
frequency and duration with which free IL-7Ra visits these
different conformations through electrostatics, sterics, overall
stability, or a combination. By shifting the equilibrium toward the
IL-7Ra conformation poised to bind IL-7, glycosylation of IL-7Ra
may increase the binding k1 on rate and affinity associated with
the IL-7/IL-7Ra interaction.
Glycosylation could affect the conformational equilibrium of
free IL-7Ra through changes local to the attached glycans or
more globally. The differences between the unglycosylated and
glycosylated IL-7Ra in complex with IL-7 are small overall, and
the variations local to the glycans are subtle. All of the glycans
extend away from the structure and do not make any contacts
with residues besides their attached Asns, except a single
H bond between the N45R glycan and residue N47R. Because
the IL-7/IL-7Ra interfaces of theunglycosylated andglycosylated
structures superimpose with negligible rmsds, any changes
induced locally by the glycans remain local and do not translate
to changes at the interface. Globally, glycosylation may stabilize
free IL-7Ra and the IL-7/IL-7Ra complex (free energy of unfold-
ing,DGu). Thermodynamic studies of EPOshowed that glycosyl-
ation increased DGu, thereby increasing the stability of the
folded state (Darling et al., 2002; Egrie and Browne, 2001). In
another example, studies have shown that the glycosylation of
N297 of the CH2 domain of the IgG-Fc arm leads to enhanced
thermal unfolding relative to the unglycosylated form and that
the glycans are essential for its binding/function to the Fc g
Figure 6. IL-7Ra Structural Comparison
among the Known Receptor Structures of
the gc Family
(A) Superimposition of the D1 domains of IL-7Ra
(green, glycosylated structure), IL-4Ra from the
binary complex (pink; PDB ID code 1IAR), and
IL-4Ra from the ternary complex (magenta; PDB
ID code 3BPL) individually superimposed onto
the D1 domain of IL-2Rb (gray; PDB ID code
2BFI).
(B) Superimposition of the D2 domains of the
receptors as described in (A). The inset defines
the three angles relating the two FNIII domains
described previously (Deivanayagam et al.,
2000). The elbow angle (e) defines the angle
between the two domains forming the distinctive
L shape of the receptor. The twist angle (t) repre-
sents the angle between the x axes of the D1 and
D2 domains. The spin of the D2 domain in the x-z
plane defines the swivel angle (s).
(C) Superimpositions of the IL-7/IL-7Ra and IL-4
ternary complexes onto the IL-2 quaternary
structures using only the D1 domains.
(D) Superimpositions of the IL-7/IL-7Ra and IL-4
ternary complexes onto the IL-2 quaternary
structure using only the D2 domains.
(E) Superimpositions of the IL-7/IL-7Ra and
IL-4 ternary complexes onto the IL-2 quater-
nary structures using both the D1 and D2
domains.62 Structure 17, 54–65, January 14, 2009 ª2009 Elsevier Ltd All rights reserved
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Structures of the IL-7/IL-7Ra Complexreceptor (FcgR) (Mimura et al., 2001), even though the N297
glycans (Fc fragment forms a dimer) do not participate directly
in the binding interface of Fc:FcgR (Sondermann et al., 2000).
Therefore, we posit that glycosylation increases the binding
constants of the IL-7/IL-7Ra interaction by increasing the ther-
modynamic stability of IL-7Ra, the 1:1 complex, or a combination
of both by shifting its conformational equilibrium to a state more
conducive to binding IL-7.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification
Proteins were expressed and purified from bacterial and S2 insect cells as
described previously (Wickham and Walsh, 2007). Recombinant human
IL-7Ra ectodomain from CHO cells was purchased from R&D Systems.
Endoglycosidase Treatment of IL-7Ra
Endoglycosidase reactions of IL-7Ra (S2) to trim the glycans directly from the
Biacore sensor chips were performed as previously described (Logsdon et al.,
2004) with the exception that 2500 U of Endo H was used. In addition, a reac-
tion temperature of 37C was used for both enzymes. Similar reactions were
used using 1 mg of soluble E217C-IL-7Ra for the competition ELISAs.
Figure 7. Hypothetical Model of the IL-7/IL-7Ra/gc Signaling
Complex
Solvent-exposed IL-7 helix D residues are colored as white sticks. The gc
(orange) residues shown to interact with the IL-7/IL-7Ra complex are colored
purple.Structure 17SPR Analysis
Experiments were performed using a Biacore 2000 or 3000 SPR instrument.
The IL-7Ra ectodomain coupling and binding kinetics were measured using
a CM5 sensor chip at 25C. IL-7Ra was coupled to a CM5 sensor chip using
amine or thiol coupling. For thiol coupling using both E. coli (EC) and S2 (S2)
insect expression systems, a C-terminal cysteine mutation (E217C) was engi-
neered into the IL-7Ra ectodomain. To remove IL-7Ra intermolecular disulfide
bonds, before thiol coupling, E217C-IL-7Ra was mildly reduced with 1.5 mM
DTT for 30 min at 4C. After reduction, IL-7Ra was immediately desalted
(PD-10 column) into 10 mM NaPO4 buffer (pH 7.4), concentrated to 200 ml,
and stored at 4C.
In preparation for thiol coupling of IL-7Ra, the CM5 sensor chip was first
washed with 10 mM HEPES (pH 7.4), 150 mM NaCl, 3 mM EDTA, and
0.005% Tween 20 at 10 ml/min for 10 min. Each flow cell was injected with
10 ml of N-hydroxysuccinimide/N-ethyl-N0-(3-dimethylaminopropyl)carbodii-
mide (NHS/EDC), followed by 20 ml of 2-(2-pyridinyldithio)ethaneamine hydro-
chloride (PDEA), and then 10–50 ml of reduced E217C-IL-7Ra (50–100 mg/ml in
10 mM sodium acetate [pH 4.5]) was injected over flow cells 2–4. Flow cell 1
served as a reference cell. Flow cells were blocked with a 35 ml injection of
50 mM reduced glutathione in 20 mM NaOAc (pH 4.5) with 1 M NaCl.
For amine coupling of IL-7Ra (CHO), the same procedure was performed as
above, but the receptor was injected after the NHS/EDC activation step.
Approximately 10–30 ml of IL-7Ra in PBS buffer was injected over flow cells
2–4 (50–100 mg/ml, typically 30 ml of IL-7Ra in 100 ml of 10 mM sodium acetate
[pH 4.5]). Flow cell 1 served as a reference. Flow cells were blockedwith a 35 ml
injection of 1 M ethanolamine (pH 8.5).
Numerous SPR control experiments were performed for the binding interac-
tions of IL-7 to both unglycosylated and glycosylated IL-7Ra that indicate that
mass transport effects were negligible. Nonspecific binding was not observed
when IL-7 was injected over the underivatized flow cells. SPR experiments
measured at 50 ml/min involved 2-fold serial dilutions of five IL-7 concentrations
determinedby thebindingaffinity to the IL-7Raectodomain.Each250ml protein/
buffer injectionwas followed by a 400 s dissociation period. The surfacewas re-
generated for subsequent runs with a 5 ml injection of 4 M MgCl2.
Sensorgrams were trimmed and double referenced (Morton et al., 1995)
using BIAevaluation 4.1 before data analysis. The IL-7 binding interaction
measured on either the thiol or amine IL-7Ra-coupled surfaces fit best to
a two-step reaction model (Morton et al., 1995):
IL-7+ IL-7Ra4
k1
k1
ðIL-7 : IL-7RaÞ4k2
k2
IL-7 : IL-7Ra: (1)
Apparent equilibrium dissociation constants (KD) were calculated from
KD = k1k2=k1ðk2 + k2Þ: (2)
Sensorgrams were globally analyzed using ClampXP (Myszka and Morton,
1998), and the binding kinetic parameters were determined from at least three
separate experiments.
Competition ELISA
Unlabeled IL-7 displaced horseradish peroxidase (HRP; Pierce) -conjugated
IL-7 from immobilized IL-7Ra. Unglycosylated and glycosylated IL-7Ra vari-
ants with the E217C mutation were thiol coupled to biotin-HPDB (N-(6-[bioti-
namido]hexyl)-30-(20-pyridyldithio)-propionamide) (Pierce). Maxisorb 96-well
plates were coated with 5 mg/ml of NeutrAvidin (Pierce) in 50 mM NaHCO3
(pH 9) overnight at 4C. The plates were washed four times with PBS and
0.05% Tween 20 (PBS-Tween). The 96-well plates were blocked with Super-
block-PBS (Pierce) and 0.05% Tween 20 for 2 hr. The unglycosylated (6 nM)
and glycosylated (1 nM) biotin-IL-7Ra variants were immobilized for 2 hr.
The plates were washed four times with PBS-Tween. Concentrations of 250
and 3 nM HRP-IL-7 were used for the unglycosylated and glycosylated
biotin-IL-7Ra displacements, respectively. Two-fold serial dilutions of unla-
beled IL-7 were initiated at 100 and 3.2 mM for the immobilized unglycosylated
and glycosylated receptors, respectively, and mixed with the fixed HRP-IL-7
concentrations. The plates were incubated for 2 hr and washed eight times
with PBS-Tween. The plates were developed using HRP chemistry and
measured at 450 nm. Displacement curves were fit to a single-site competition
model and experiments were triplicated., 54–65, January 14, 2009 ª2009 Elsevier Ltd All rights reserved 63
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Protein crystallization of the unglycosylated and glycosylated complexes has
been reported elsewhere (Wickham and Walsh, 2007). The protein complexes
that diffracted incorporated a surface-loop mutation, E106A, in IL-7 (Wickham
and Walsh, 2007). Another glycosylated native data set was collected on
a larger pyramidal shaped crystal and merged with a previously described
data set (Wickham and Walsh, 2007). In addition, a platinum derivative of the
glycosylated complex was prepared by soaking a crystal in 10 mM K2PtCl6
for 2 hr. Protein crystals were flash frozen in liquid nitrogen after transfer into
15%–20% glycerol with the appropriate mother liquor. X-ray data were
collected at the Structural Biology Center 19ID beamline, Advanced Photon
Source, Argonne National Laboratories, Chicago, IL, USA and processed
using HKL-3000 (Minor et al., 2006).
The crystal structure of the unglycosylated complex was solved using
a three-wavelength multiwavelength anomalous diffraction data set collected
on a crystal that incorporated selenomethionine into E106A-IL-7 (EC). Mass
spectrometry indicated that 5–6 selenomethionines were substituted for the
6 methionines in E106A-IL-7. SHELXD (Schneider and Sheldrick, 2002) only
located 5 of the 10–12 predicted SeMet heavy atoms from the SeMet-
substituted complex crystal. Heavy-atom refinement, phasing, and density
modification were performed using autoSHARP to 3.0 A˚ (Bricogne et al.,
2003; Vonrhein et al., 2007). Automatic chain tracing, noncrystallographic
symmetry (NCS) averaging, and phase combination of the model and experi-
mental information were performed using RESOLVE (Terwilliger, 2003), DM
(Cowtan and Main, 1998), and SIGMAA (CCP, 1994). Coot (Emsley and Cow-
tan, 2004) was used for model building. Simulated annealing torsional angle
dynamics, conjugate gradient energy minimization, an overall anisotropic
temperature factor and bulk solvent correction, and B factor refinement
were performed using CNS 1.2 (Brunger, 2007). NCS restraints were employed
using a force constant of 150 kcal/mol A˚2 as listed in Table S1 by comparing
the Rfree values with and without the restraints.
The crystal structure of the glycosylated IL-7 (EC):IL-7Ra (S2) complex was
solved by combining phases of a Pt derivative with a molecular replacement
solution from EPMR (Kissinger et al., 2001) using the unglycosylated IL-7/
IL-7Ra complex as the search model. Two Pt sites were identified by SHELXD.
Experimental phases were calculated in autoSHARP using the single isomor-
phouswith anomalous scatter (SIRAS) strategy. The phase-combined electron
densitymapwas sharperwith the Pt data.Molprobity (Davis et al., 2007), CCP4
(CCP, 1994), and PISA (Krissinel and Henrick, 2007) were used for structural
validation and analysis. All structural figures were created using PyMOL
(http://pymol.sourceforge.net).
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